TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/13/24 19:48 | 2/13/24 | HLXB | Helix Acquisition Corp. II | E9 | Financ | AcqCo | Blank Checks | 1 | 1 | P | 24,000 | 10.00 | 0 | 2,400 | 904 | I | |||||||||||||||
10/10/23 16:00 | 10/5/23 | MLTX | Moonlake Immunotherapeutics | E9 | Health | Drug | Pharmaceutical Preparations | 1 | 5 | P.m | 97,634 | 40.19 | 0 | 2,429 | 39 | 8,604 | I | ||||||||||||||
4/3/23 16:30 | 3/30/23 | BMEA | Biomea Fusion, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 1 | P.d | 12,000 | 30.00 | 0 | 400 | 13 | 3,571 | I | ||||||||||||||
12/21/22 16:33 | 12/13/22 | ERAS | Erasca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 2 | P.d | 4,000 | 6.50 | 0 | 615 | 6 | 10,813 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |